Our Team

Scott has over 25 years experience in  the Cell and Gene Therapy space overseeing strategy; process development; manufacturing and release  of viral  and non-viral vectors, cell therapies and plasmids; analytics; CDMO management; fill-finish; cleanroom design, buildout, and commissioning of manufacturing facilities, 

After completing his graduate work, Scott worked for Merck Research Laboratories and Merck Manufacturing Division in West Point, PA manufacturing and releasing an adenovirus based HIV gag/pol vaccine, and the Hepatitis A and B vaccines. He then managed the Indiana University Vector Production Facility and National Gene Vector Laboratory (NGVL), where he was responsible for lentiviral and retroviral GMP manufacturing, GMP testing and release, the PD suite, and the design, construction and commissioning of the IUVPF GMP manufacturing facility. 

Scott then joined the team at Cincinnati Children’s Hospital Medical Center (CCHMC) whre he managed the GMP vector manufacturing facility, the viral vector core, and the aseptic processing suites before moving down to warmer weather to join the University of Florida’s Florida Biologix as the Director of Cell Therapy, Fill Finish, and Vector Support Operations.  

Shortly after the Florida Biologix spinout and formation of Brammer Bio, Scott joined the startup Orchard Therapeutics  where he was one of the original 10 company members and the Vice President of Vector Operations.  Scott has spent the last 5 years of his career as the Head of Gene Therapy CMC and a Sr. Prnicipal at Dark Horse Consulting Group.  Scott’s desire to bring C&GT products to market quickly and in a cost effective manner, has led him to start ATMP Consulting Group, where experience, speed, and lower costs help expand the field.

Contact Scott at: Scott@ATMPconsult.com